These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 14500756

  • 1. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, Yagi M, Sato M, Suzuki R, Murooka H, Sakai T, Nishitoba T, Im DS, Nochi H, Tamoto K, Tomura H, Okajima F.
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [Abstract] [Full Text] [Related]

  • 2. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells.
    Masiello LM, Fotos JS, Galileo DS, Karin NJ.
    Bone; 2006 Jul; 39(1):72-82. PubMed ID: 16487757
    [Abstract] [Full Text] [Related]

  • 3. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.
    Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H.
    J Cell Sci; 2003 May 15; 116(Pt 10):1969-80. PubMed ID: 12668728
    [Abstract] [Full Text] [Related]

  • 4. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W.
    Circulation; 2003 Aug 12; 108(6):741-7. PubMed ID: 12885756
    [Abstract] [Full Text] [Related]

  • 5. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
    Noguchi K, Ishii S, Shimizu T.
    J Biol Chem; 2003 Jul 11; 278(28):25600-6. PubMed ID: 12724320
    [Abstract] [Full Text] [Related]

  • 6. Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cells.
    Moughal NA, Waters CM, Valentine WJ, Connell M, Richardson JC, Tigyi G, Pyne S, Pyne NJ.
    J Neurochem; 2006 Sep 11; 98(6):1920-9. PubMed ID: 16945108
    [Abstract] [Full Text] [Related]

  • 7. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS.
    Cell Signal; 2013 Nov 11; 25(11):2147-54. PubMed ID: 23838008
    [Abstract] [Full Text] [Related]

  • 8. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.
    Im DS, Heise CE, Harding MA, George SR, O'Dowd BF, Theodorescu D, Lynch KR.
    Mol Pharmacol; 2000 Apr 11; 57(4):753-9. PubMed ID: 10727522
    [Abstract] [Full Text] [Related]

  • 9. Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.
    Heasley BH, Jarosz R, Lynch KR, Macdonald TL.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2735-40. PubMed ID: 15125924
    [Abstract] [Full Text] [Related]

  • 10. Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors.
    Fischer DJ, Nusser N, Virag T, Yokoyama K, Wang Da, Baker DL, Bautista D, Parrill AL, Tigyi G.
    Mol Pharmacol; 2001 Oct 07; 60(4):776-84. PubMed ID: 11562440
    [Abstract] [Full Text] [Related]

  • 11. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
    Kostenis E.
    J Cell Biochem; 2004 Aug 01; 92(5):923-36. PubMed ID: 15258916
    [Abstract] [Full Text] [Related]

  • 12. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
    Okusa MD, Ye H, Huang L, Sigismund L, Macdonald T, Lynch KR.
    Am J Physiol Renal Physiol; 2003 Sep 01; 285(3):F565-74. PubMed ID: 12770838
    [Abstract] [Full Text] [Related]

  • 13. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor.
    Woclawek-Potocka I, Kondraciuk K, Skarzynski DJ.
    Exp Biol Med (Maywood); 2009 Aug 01; 234(8):986-93. PubMed ID: 19491366
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
    Subramanian P, Karshovska E, Reinhard P, Megens RT, Zhou Z, Akhtar S, Schumann U, Li X, van Zandvoort M, Ludin C, Weber C, Schober A.
    Circ Res; 2010 Jul 09; 107(1):96-105. PubMed ID: 20360252
    [Abstract] [Full Text] [Related]

  • 15. Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures.
    Guillot E, Le Bail JC, Paul P, Fourgous V, Briand P, Partiseti M, Cornet B, Janiak P, Philippo C.
    J Pharmacol Exp Ther; 2020 Aug 09; 374(2):283-294. PubMed ID: 32409422
    [Abstract] [Full Text] [Related]

  • 16. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
    Xu Y, Jiang G, Tsukahara R, Fujiwara Y, Tigyi G, Prestwich GD.
    J Med Chem; 2006 Aug 24; 49(17):5309-15. PubMed ID: 16913720
    [Abstract] [Full Text] [Related]

  • 17. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
    Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H.
    Exp Cell Res; 2004 Dec 10; 301(2):168-78. PubMed ID: 15530853
    [Abstract] [Full Text] [Related]

  • 18. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A, Sinomiya J, Kishimoto S, Tanaka T, Kogure K, Sugiura T, Satouchi K, Waku K, Fukuzawa K.
    Biochem J; 2002 Aug 01; 365(Pt 3):617-28. PubMed ID: 11982483
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
    Durgam GG, Tsukahara R, Makarova N, Walker MD, Fujiwara Y, Pigg KR, Baker DL, Sardar VM, Parrill AL, Tigyi G, Miller DD.
    Bioorg Med Chem Lett; 2006 Feb 01; 16(3):633-40. PubMed ID: 16263282
    [Abstract] [Full Text] [Related]

  • 20. Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells.
    Lee SY, Lee HY, Kim SD, Jo SH, Shim JW, Lee HJ, Yun J, Bae YS.
    Biochem Biophys Res Commun; 2008 Sep 12; 374(1):147-51. PubMed ID: 18616930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.